Cargando…
The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
Pediatric Crohn’s disease (CD) carries a higher genetic susceptibility and an increased risk of a more aggressive disease course than adult CD. Treatment of CD is based on immunomodulatory drugs, such as thiopurines. The enzyme mainly involved in drug metabolism is thiopurine S-methyltransferase (TP...
Autores principales: | Ha, Changhee, Kim, Eun Sil, Kwon, Yiyoung, Choe, Yon Ho, Kim, Mi Jin, Lee, Soo-Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705256/ https://www.ncbi.nlm.nih.gov/pubmed/33273844 http://dx.doi.org/10.2147/PGPM.S279446 |
Ejemplares similares
-
Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk
por: Nguyen, Christine M., et al.
Publicado: (2011) -
Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn’s disease than in European patients
por: Kim, Eun Sil, et al.
Publicado: (2020) -
In Vitro Protein Stability of Two Naturally Occurring
Thiopurine S-Methyltransferase Variants: Biophysical Characterization
of TPMT*6 and TPMT*8
por: Wennerstrand, Patricia, et al.
Publicado: (2017) -
Monitoring Thiopurine Metabolites in Korean Pediatric Patients with Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2014) -
Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn’s disease patients with secondary loss of response
por: Kim, Eun Sil, et al.
Publicado: (2023)